Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Title SolGel Technologies Q4 Financial Results Slight Miss in Earnings Revenue Increase

Elaine Mendonca by Elaine Mendonca
March 13, 2024
in Breaking News
0
Biotechnology Stock Bull Market
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Sol-Gel Technologies unveiled its Q4 financial results on March 13, 2024. Surprisingly, the company fell short of projected earnings by a mere 0.0%, recording an EPS of $-0.17 in contrast to the anticipated $-0.17. Revenue saw a notable increase of $347 thousand compared to the same period last year.

Interestingly, in the previous quarter, Sol-Gel exceeded EPS expectations by $0.02, causing a 7.000000000000001% decrease in share price the following day. To delve deeper into Sol-Gel Technologies’ earnings updates, explore their earnings calendar on Nasdaq’s official website.

SLGL Stock Declines Near 52-Week Low: Investors Advised to Monitor Performance Closely

On March 13, 2024, SLGL stock experienced a decline in its performance, trading near the bottom of its 52-week range and below its 200-day simple moving average. According to data from CNN Money, the price of SLGL shares decreased by $0.02 since the market last closed, representing a 2.37% drop. Investors potentially selling off their shares in response to the downward trend. It is important for investors to consider the overall market conditions and company-specific factors when analyzing stock performances. Conduct thorough research and analysis before making any investment decisions. Keep a close eye on SLGL’s performance in the coming days to see if the stock can rebound from the recent drop. Monitoring price movements, market trends, and company news can provide valuable insights into the future performance of SLGL stock.

SLGL Stock Performance Review: Total Revenue and Net Income Decline, but Signs of Improvement in Recent Quarter

On March 13, 2024, SLGL stock experienced a mixed performance as the company reported its financial results for the past year and the most recent quarter. According to data from CNN Money, SLGL’s total revenue for the past year was $3.88 million, which represents a significant decrease of 87.58% compared to the previous year. Additionally, the total revenue for the most recent quarter was $213,000, showing a decrease of 64.14% since the last quarter.

In terms of net income, SLGL reported a net loss of $14.92 million for the past year, marking a staggering decrease of 563.3% compared to the previous year. However, the net loss for the most recent quarter was $5.71 million, which actually represents a 4.34% increase since the last quarter.

Earnings per share (EPS) also saw a decline for SLGL, with an EPS of -$0.65 for the past year, reflecting a decrease of 571.98% compared to the previous year. On the other hand, the EPS for the most recent quarter was -$0.21, showing a 4.96% increase since the last quarter.

Overall, SLGL stock performance on March 13, 2024, was impacted by the significant decrease in total revenue and net income compared to the previous year. However, the slight improvement in net income and EPS since the last quarter could be seen as a positive sign for the company’s financial health. Investors and analysts will likely keep a close eye on SLGL’s future financial reports to gauge the company’s performance and potential for growth.

Tags: SLGL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Mobile app for healthcare

Innovative Device Quell Fibromyalgia Prescribed to Over 2000 Patients

Real-estate-investing

Essential Properties Realty Trust Inc Market Cap Earnings Report and Shareholder Insights

Radio telecommunications

WideOpenWest Inc Faces Stock Dip After Fourth Quarter Results

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com